Shanghai MicroPort MedBot (Group) (SEHK:2252) Wins EU CE Mark, Is The Valuation Already Too Rich?

Simply Wall St.07-03

Shanghai MicroPort MedBot (Group) (SEHK:2252) is in focus after its Toumai Remote laparoscopic surgery robot received the EU CE Mark, opening access to more than 30 European markets and providing ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2648658441?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638","is_english":true,"pubTime":"2026-07-03 11:38","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2648658441","market":"hk","top_or_hot":-1,"title":"Shanghai MicroPort MedBot (Group) (SEHK:2252) Wins EU CE Mark, Is The Valuation Already Too Rich?","media":"Simply Wall St.","content":"<div>\n<p>Shanghai MicroPort MedBot (Group) (SEHK:2252) is in focus after its Toumai Remote laparoscopic surgery robot received the EU CE Mark, opening access to more than 30 European markets and providing ...</p>\n\n<a href=\"https://simplywall.st/stocks/hk/healthcare/hkg-2252/shanghai-microport-medbot-group-shares/news/shanghai-microport-medbot-group-sehk2252-wins-eu-ce-mark-is\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Shanghai MicroPort MedBot (Group) (SEHK:2252) Wins EU CE Mark, Is The Valuation Already Too Rich?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nShanghai MicroPort MedBot (Group) (SEHK:2252) Wins EU CE Mark, Is The Valuation Already Too Rich?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-07-03 11:38 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/hk/healthcare/hkg-2252/shanghai-microport-medbot-group-shares/news/shanghai-microport-medbot-group-sehk2252-wins-eu-ce-mark-is><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Shanghai MicroPort MedBot (Group) (SEHK:2252) is in focus after its Toumai Remote laparoscopic surgery robot received the EU CE Mark, opening access to more than 30 European markets and providing ...</p>\n\n<a href=\"https://simplywall.st/stocks/hk/healthcare/hkg-2252/shanghai-microport-medbot-group-shares/news/shanghai-microport-medbot-group-sehk2252-wins-eu-ce-mark-is\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4588","symbol_name":"碎股","start_time":0,"source_url":"https://simplywall.st/stocks/hk/healthcare/hkg-2252/shanghai-microport-medbot-group-shares/news/shanghai-microport-medbot-group-sehk2252-wins-eu-ce-mark-is","article_id":"2648658441","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/healthcare/hkg-2252/shanghai-microport-medbot-group-shares/news/shanghai-microport-medbot-group-sehk2252-wins-eu-ce-mark-is","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2648658441","pubTimestamp":1783049905,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"Shanghai MicroPort MedBot (Group) (SEHK:2252) is in focus after its Toumai Remote laparoscopic surgery robot received the EU CE Mark, opening access to more than 30 European markets and providing formal regulatory recognition of remote surgery.\nSee our latest analysis for Shanghai MicroPort MedBot (Group).\nThe Toumai Remote CE Mark news comes as Shanghai MicroPort MedBot (Group)'s 1 day share price return of 1.57% and 7 day share price return of 4.20% contrast with weaker 30 and 90 day share...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4588":"碎股","02252":"微创机器人-B","CE":"塞拉尼斯","BK4156":"煤与消费用燃料","BK4585":"ETF&股票定投概念","BK1100":"医疗保健设备","DCF":"Dreyfus Alcentra Global Credit Income 2024 Target Term Fund, Inc","BK4109":"特种化学制品","BK1617":"AI医疗"},"translate_title":"上海微创医疗机器人（集团）（SEHK：2252）荣获欧盟CE标志，估值是否已经太丰厚？","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02252":0.9,"CE":1.5,"DCF":1},"content_text":"Shanghai MicroPort MedBot (Group) (SEHK:2252) is in focus after its Toumai Remote laparoscopic surgery robot received the EU CE Mark, opening access to more than 30 European markets and providing formal regulatory recognition of remote surgery. See our latest analysis for Shanghai MicroPort MedBot (Group). The Toumai Remote CE Mark news comes as Shanghai MicroPort MedBot (Group)'s 1 day share price return of 1.57% and 7 day share price return of 4.20% contrast with weaker 30 and 90 day share price returns, while the 1 year total shareholder return of 42.25% points to stronger long term momentum. If you are interested in how surgical robotics fits into the broader automation trend, it can be useful to scan other opportunities in 29 robotics and automation stocks With Shanghai MicroPort MedBot (Group) trading below some valuation estimates yet already delivering a 42.25% 1 year total shareholder return, the key question is whether the stock is still mispriced or if markets are already discounting future growth. AdvertisementPrice to Sales of 37.8x: Is It Justified for Shanghai MicroPort MedBot (Group)? On the numbers available, Shanghai MicroPort MedBot (Group) trades on a P/S of 37.8x, which is far above both its Hong Kong Medical Equipment industry and peer averages, even though some valuation models point to a discount to fair value. The P/S ratio compares the company’s market value to its revenue and is often watched closely for high growth, early stage businesses that are not yet profitable. For a company like Shanghai MicroPort MedBot (Group), which is still loss making but reported CN¥551.07m in revenue from selling surgical robots and related medical devices, the market is effectively placing a high value on each unit of current sales. That 37.8x P/S stands against an industry average of 3.2x and a peer average of 13.7x. This implies investors are paying a multiple of sales that is well above both sector norms and the estimated fair P/S of 6x that some models suggest the market could eventually move toward. Explore the SWS fair ratio for Shanghai MicroPort MedBot (Group) Result: Price to Sales of 37.8x (OVERVALUED) However, Shanghai MicroPort MedBot (Group) still carries risks, including ongoing net losses of CN¥249.66m and a high 37.8x P/S that could prove fragile. Find out about the key risks to this Shanghai MicroPort MedBot (Group) narrative. Another View on Shanghai MicroPort MedBot (Group)'s Valuation While the 37.8x P/S suggests Shanghai MicroPort MedBot (Group) is expensive versus its industry, the SWS DCF model provides a different perspective, with an estimated value of HK$40.69 per share compared with the current HK$23.3. This implies the stock is undervalued based on projected cash flows. Which signal do you consider more informative? Look into how the SWS DCF model arrives at its fair value. 2252 Discounted Cash Flow as at Jul 2026Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Shanghai MicroPort MedBot (Group) for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 203 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity. Next Steps If this mix of signals on Shanghai MicroPort MedBot (Group) leaves you unsure, act while the data is fresh and test the thesis yourself by reviewing the 2 key rewards. Looking for more investment ideas beyond Shanghai MicroPort MedBot (Group)? Round out your view on Shanghai MicroPort MedBot (Group) by checking how other opportunities stack up on quality, risk and income potential using the Simply Wall St Screener.  Spot potential income anchors by reviewing companies in the 480 dividend fortresses that may offer higher yields than you currently hold. Zero in on quality at a possible discount by scanning the 203 high quality undervalued stocks and seeing which stocks line up with your return and risk expectations. Strengthen your downside protection by assessing companies in the 296 resilient stocks with low risk scores that could help balance out more volatile positions.   This article by Simply Wall St is general in nature. We provide commentary based on historical data\n        and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n        financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n        Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n        Simply Wall St has no position in any stocks mentioned.New: Manage All Your Stock Portfolios in One PlaceWe've created the ultimate portfolio companion for stock investors, and it's free.• Connect an unlimited number of Portfolios and see your total in one currency• Be alerted to new Warning Signs or Risks via email or mobile• Track the Fair Value of your stocksTry a Demo Portfolio for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":false,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.45.0","shortVersion":"4.45.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2648658441","isCrawlerRequest":true}